Si-Bone (SIBN) Operating Income Growth (5y) (2022 - 2026)
Si-Bone (SIBN) Operating Income Growth (5y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.52 Bn | 176.22 Bn | 6.27 Bn |
| 2 | Stryker | 128.83 Bn | 125.95 Bn | 3.81 Bn |
| 3 | Medtronic | 108.61 Bn | 99.39 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.35 Bn | 66.90 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.53 Bn | 44.86 Bn | 1.29 Bn |
| 6 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - |
| 9 | Koninklijke Philips | 25.49 Bn | 22.36 Bn | 2.07 Bn |
| 10 | Si-Bone | 756.11 Mn | 611.42 Mn | 41.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.14% |
| Dec 31, 2025 | 20.73% |
| Sep 30, 2025 | 9.10% |
| Jun 30, 2025 | 7.13% |
| Mar 31, 2025 | 8.84% |
| Dec 31, 2024 | 8.33% |
| Sep 30, 2024 | 6.32% |
| Jun 30, 2024 | -4.37% |
| Mar 31, 2024 | -6.48% |
| Dec 31, 2023 | -23.76% |
| Sep 30, 2023 | -29.69% |
| Jun 30, 2023 | -47.79% |
| Mar 31, 2023 | -31.09% |
| Dec 31, 2022 | -47.08% |
| Sep 30, 2022 | -21.90% |